Results 101 to 110 of about 5,389 (128)

Novel biopharmaceutical strategies: Fc-fusion protein technology. [PDF]

Front Pharmacol
Ding XY, Fan HL, Zhang CM, Wei MX, Lin ZZ, Bai CJ, Wang MY, Zhou HH.   +7 more
europepmc   +1 more source

Research Progress in Pharmacological Targeted Therapy for Myasthenia Gravis. [PDF]

J Inflamm Res
Zhou Y, Wu Y, Meng Z.
europepmc   +1 more source

From Payload-First Toward Dual-Mechanism Antibody-Drug Conjugates. [PDF]

Adv Mater
Pivot X, Jung S, Harlepp S, Detappe A.
europepmc   +1 more source

Age and Treatment Efficacy in Myasthenia Gravis: A Systematic Review, Meta-Analysis, and Meta-Regression. [PDF]

Eur J Neurol
Nelke C, Skrobol M, Theissen L, Sacca F, Ruck T.   +4 more
europepmc   +1 more source

Fc-engineering for improved cancer immunotherapy. [PDF]

Biochem Soc Trans
Borgman E, Le Gall C, Ploegh H, Pishesha N.   +3 more
europepmc   +1 more source

Ontogeny of Placental FcRn Protein During Human and Animal Pregnancy to Inform Developmental Toxicity Testing. [PDF]

Birth Defects Res
Bowman CJ, Breslin WJ, Chen C, Foster W, Hui J, Kusmider B, Laffan S, Myers M, Sivaraman L, Tornesi B, Westmoreland S, DeSesso JM.   +11 more
europepmc   +1 more source

Depemokimab: toward biannual biologic therapy for severe eosinophilic asthma. [PDF]

Respir Res
Papavassiliou KA, Gogou VA, Papavassiliou AG.   +2 more
europepmc   +1 more source

Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic Coronaviruses. [PDF]

J Med Virol
Helal A, Aljehani ND, Ghazwani A, Alsulaiman RM, Alyami F, Abdulaal WH, Alsharef A, Alghanmi M, Zawawi A, Azhari AA, Almehmadi A, Balula J, Altorki T, Alhabbab RY, Khan MY, Alluhaybi K, Alnami A, Neamatallah T, Abujamel TS, Alfaleh MA, Hashem AM.   +20 more
europepmc   +1 more source

Particles of echovirus 18 open to release their genomes in vivo. [PDF]

Proc Natl Acad Sci U S A
Mukhamedova L, Buchta D, Trebichalská Z, Levdansky Y, Moravcová J, Potěšil D, Zdráhal Z, Hrebík D, Nepovímová L, Gjølberg TT, Andersen JT, Nováček J, Füzik T, Plevka P.   +13 more
europepmc   +1 more source

Case Report: Anti-LGI1 encephalitis during FcRn inhibition with efgartigimod for myasthenia gravis: implications for the limitations of IgG recycling blockade. [PDF]

Front Immunol
Komatsu Y, Eura N, Nishimori Y, Kakehi Y, Kiriyama T, Sugie K.   +5 more
europepmc   +1 more source